Mariana Oncology to be Acquired by Novartis to Advance Preci

Mariana Oncology a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer today announced it will be acquired by Novartis for 1 billion upfront and up to 750 million in potential milestone payments.

Related Keywords

United States , Chris Brinzey , Goodwin Procter , Biomedical Research At Novartis , Atlas Venture , Novartis , Centerview Partners , Mariana Oncology , Simon Read , Shiva Malek , Global Head , Biomedical Research , Access Biotechnology , Deeptrack Capital , Media Contact ,